Literature DB >> 18367165

JNJ16259685, a selective mGlu1 antagonist, suppresses isolation-induced aggression in male mice.

José Francisco Navarro1, Vanessa De Castro, Mercedes Martín-López.   

Abstract

mGlu1 receptors are present in brain regions involved in aggression modulation. This study examines the effects of 3-4-Dihydro-2H-pyrano[2,3-b]quinolin-7-yl-(cis-4-methoxycyclohexyl)-methanone (JNJ16259685; 0.125, 0.25, 0.5, 1, 2, 4 and 8 mg/kg, i.p), a selective antagonist of the mGlu1 receptors, on agonistic interactions between male mice. Individually housed mice were exposed to anosmic "standard opponents" 30 min after drug administration. Ten minutes of diadic interactions was staged between a singly housed and an anosmic mouse in a neutral area. The encounters were videotaped and the accumulated time allocated by subjects to ten broad behavioural categories was estimated using an ethologically based analysis. JNJ16259685 (all doses) produced a significant reduction of offensive behaviours (threat and attack), without affecting immobility. These findings suggest for the first time a role for mGlu1 receptors in aggression regulation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18367165     DOI: 10.1016/j.ejphar.2008.02.070

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Cerebrospinal fluid glutamate concentration correlates with impulsive aggression in human subjects.

Authors:  Emil F Coccaro; Royce Lee; Paul Vezina
Journal:  J Psychiatr Res       Date:  2013-06-18       Impact factor: 4.791

Review 2.  Neurogenetics of aggressive behavior: studies in rodents.

Authors:  Aki Takahashi; Klaus A Miczek
Journal:  Curr Top Behav Neurosci       Date:  2014

3.  Anger management: Mechanisms of glutamate receptor-mediated synaptic plasticity underlying animal aggression.

Authors:  Jacob C Nordman
Journal:  Int J Biochem Cell Biol       Date:  2021-11-23       Impact factor: 5.085

Review 4.  Elucidating the mechanism of action of pregabalin: α(2)δ as a therapeutic target in anxiety.

Authors:  Juan-Antonio Micó; Rita Prieto
Journal:  CNS Drugs       Date:  2012-08-01       Impact factor: 6.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.